The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 4 February 2025, approved the vaccine chikungunya vaccine (live) (brand name ...
The single-dose vaccine is indicated for active immunization for the prevention of disease caused by chikungunya virus ... that a single dose of the live-attenuated IXCHIQ ® vaccine induces ...
UK MHRA grants marketing authorization to Valneva’s chikungunya vaccine, Ixchiq: Saint Herblain, France Thursday, February 6, 2025, 12:00 Hrs [IST] Valneva SE, a specialty vacci ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results